Antigenic transformation in plasma cell dyscrasia

Area of Science:

• Hematology
• Immunophenotyping
• Flow Cytometry

Background:

• The World Health Organization (WHO) defines the immunophenotype for plasma cell myeloma.
• This includes characteristic expression patterns of CD markers like CD19, CD20, CD38, CD138, CD56, and CD10.
• Accurate immunophenotyping is crucial for diagnosing plasma cell dyscrasias.

Purpose of the Study:

• To evaluate the utility of quantitative fluorescence intensity in the flow cytometric analysis of CD molecular expression.
• To assess the expression patterns of various CD markers in plasma cell dyscrasia cases.
• To correlate these findings with the established WHO immunophenotype for plasma cell myeloma.

Main Methods:

• Flow cytometry was used to quantify the mean fluorescence intensities (MFI) of CD38, CD138, CD56, and CD19.
• 39 cases of plasma cell dyscrasia were analyzed.
• Expression levels of CD117, CD20, and CD10 were also assessed.

Main Results:

• CD19 was absent in 97.4% of cases, while CD138 and CD38 were expressed in 100%.
• CD38 and CD138 showed bright expression (MFI > 501).
• CD56 expression varied, with dual CD38/CD56 expression in 64.1% and negativity in 40% of cases.

Conclusions:

• Quantitative fluorescence intensity provides valuable data for flow cytometric evaluation.
• This method enhances the diagnosis of hematopathologic disorders like plasma cell dyscrasia.
• Consistent expression patterns of CD markers support their role in diagnosis.